A New Frontier in the Co-Management of Thyroid Eye Disease

By: Annenberg Center for Health Sciences
Listen for free

  • Summary

  • Thyroid eye disease, also known as Graves’ orbitopathy, is a potentially serious, progressive autoimmune disease that most often occurs in people with hyperthyroidism, ie, Graves’ disease. Kimberley Cockerham, MD, FACS, moderates this series of six, paired conversations between endocrinologist Terry J. Smith, MD, and eye specialists Wendy W. Lee, MD, and Raymond Douglas, MD, PhD, to explore current and emerging treatment options for thyroid eye disease. In these conversations, faculty review the current understanding of the burden and pathophysiology of thyroid eye disease—including treatment
    Annenberg Center for Health Sciences
    Show More Show Less
Hygiene & Healthy Living Physical Illness & Disease
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Radiation, Surgery

    Radiation, Surgery
    Sep 24 2021
    • The role for external beam radiation and orbital decompression in treating patients with thyroid eye disease
    • Other surgical options for treating patients with thyroid eye disease
    Show More Show Less
    13 mins
  • Clinical Trials Experience

    Clinical Trials Experience
    Sep 24 2021
    • Clinical data supporting the approval of teprotumumab
    • How efficacy was assessed in the teprotumumab trials
    • Emerging therapies for patients with thyroid eye disease
    Show More Show Less
    16 mins
  • Treatment

    Treatment
    Sep 24 2021
    • The role of intervention in patient management
    • Therapy selection for patients with thyroid eye disease
    • Evaluating treatment responses
    Show More Show Less
    15 mins

What listeners say about A New Frontier in the Co-Management of Thyroid Eye Disease

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available